Skip to content

A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza

A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01192958
Acronym
Snuffles
Enrollment
Unknown
Registered
2010-09-01
Start date
2010-01-31
Completion date
2010-07-31
Last updated
2010-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H1N1 Virus

Keywords

swine flu, novel h1n1v, novel h1n1, h1n1

Brief summary

At present influenza immunity can only be reliably confirmed by a blood test. This test is invasive for the patient. This study is intended to validate an oral fluid/saliva antibody test for the variant Swine Influenza H1N1. If such a test were available, this painless and non invasive test will improve direct clinical care to an individual as well as significantly help guide future public health management of the pandemic.

Interventions

None listed

Sponsors

Public Health England
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
ALL
Age
6 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants of the clinical service evaluation of novel H1N1v vaccine * First or second blood sample for the clinical service evaluation successfully collected

Exclusion criteria

* Withdrawn from clinical service evaluation of novel H1N1v vaccine * Second blood sample for the clinical service evaluation not collected.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026